- Home
- Products
Orilissa (Elagolix)
Orilissa (Elagolix)
- Medicine Name: Orilissa
- Generic Name: Elagolix
- Dosage Form & Strength: Tablets – 150 mg and 200 mg
- Manufactured By: AbbVie
Orilissa is an oral gonadotropin-releasing hormone (GnRH) receptor antagonist used for the management of moderate to severe pain associated with endometriosis in women.
Recommended Dosage:
- 150 mg once daily for up to 24 months (for normal or mild hepatic impairment)
- 200 mg twice daily for up to 6 months
- 150 mg once daily for 6 months in patients with moderate hepatic impairment
- Take at the same time daily, with or without food
- Use the lowest effective dose based on the severity of symptoms
Missed Dose: Take as soon as remembered on the same day and resume regular schedule
Bone Mineral Density (BMD) Loss: Prolonged use may result in dose-dependent reduction in BMD, which may not be reversible. Contraindicated in women with osteoporosis.
Menstrual Suppression: May alter menstrual bleeding patterns, masking early pregnancy signs. Discontinue treatment if pregnancy is confirmed.
Suicidal Thoughts or Behavior: Reported in clinical trials. Patients should seek immediate help if symptoms occur.
Liver Function: ALT elevations may occur. Monitor liver function; assess risk/benefit if abnormalities are noted.
Required Documents to Import Orilissa into India:
- Valid doctor’s prescription
- Diagnostic reports confirming endometriosis
- Government-issued ID of the patient
Availability in India:
Orilissa is a prescription-only medication and can be imported via the Named Patient Program. Global Rare Meds facilitates access across major Indian cities including Mumbai, Delhi, Chennai, Bengaluru, Pune, Hyderabad, and others.
📧 info@globalraremeds.com
📞 +91-99675 15602 (Call/WhatsApp)
Global Rare Meds sources Orilissa (Elagolix) from certified international suppliers and delivers through our licensed fulfillment center in Ambernath, Thane District, ensuring:
- Regulatory-compliant import
- Verified global sourcing from the USA, Canada, Europe, and Australia
- Pharmacist-verified dispensing
- Nationwide delivery with quality assurance
Q: What is the generic name of Orilissa®?
A: Elagolix
Q: Who manufactures Orilissa®?
A: AbbVie
Q: What is Orilissa® used for?
A: It is used to treat moderate to severe endometriosis-related pain.
Q: Is Orilissa® FDA-approved?
A: Yes, approved by the FDA on July 23, 2018.
Q: What dosages are available?
A: Tablets in 150 mg and 200 mg strengths.
Q: What are common side effects?
A: Headache, hot flushes, night sweats, mood changes, amenorrhea, joint pain, insomnia, and depression-related symptoms.
Q: Are there storage requirements?
A: Store at 2°C to 30°C (36°F to 86°F) in a dry place away from direct light.
Q: How much does Orilissa® cost in India?
A: Price varies by dose and source. Contact info@globalraremeds.com or +91-99675 15602 for a quote.
Q: Is it legal and safe to buy Orilissa® online in India?
A: Yes, Global Rare Meds facilitates legal import with a valid prescription and supports compliant access through international pharmacy partners.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
